Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYNCARDIA-HF: Semaglutide Added to Dapagliflozin in Heart Failure with Prosthetic Valve Replacement
NCT07610174Phase 2Completed
- Sponsor
- Kafrelsheikh University
- Start
- Jun 2025
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
A Phase 2 trial of semaglutide in heart failure (HF), sponsored by Kafrelsheikh University. Started Jun 2025; status: completed.
02
Drugs
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT07610174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07610174.